Assignee
SMITH HENRY JOHN
US·3 granted patents·10 pending applications·10 citations·filing 2003–2017
Top patents by PatentIndex Score
13 records- 0172US7799327B2Autoantibodies utilized as carrier agents for pharmaceutical compounds used in cancer treatmentSMITH HENRY JOHN·Filed 2003·Granted Sep 21, 2010·4 cites·18 claims
- 0271US9128085B2Rapid test for glycated albumin in bloodSMITH HENRY JOHN·Filed 2009·Granted Sep 8, 2015·3 cites·11 claims
- 0370US2010086585A1Antinuclear antibody utilized as a targeting agent for pharmaceutical compounds used in the treatment of cancer and other diseasesSMITH HENRY JOHN·Filed 2009·Application pending·0 cites
- 0464US8979787B2Treatment of pre-eclampsia using targeted apheresisSMITH HENRY JOHN·Filed 2012·Granted Mar 17, 2015·3 cites·7 claims
- 0559US2009041837A1Aptamers utilized as targeting agents for pharmaceutical compounds used in the treatment of cancer and other diseasesSMITH HENRY JOHN·Filed 2008·Application pending·0 cites
- 0654US2009042237A1Aptamer based point-of-care test for glycated albuminSMITH HENRY JOHN·Filed 2008·Application pending·0 cites
- 0754US2012231066A1Multi-drug liposomes to treat tumorsSMITH HENRY JOHN·Filed 2012·Application pending·0 cites
- 0848US2010167306A1Rapid test for glycated albumin in salivaSMITH HENRY JOHN·Filed 2008·Application pending·0 cites
- 0947US2013101663A1Soluble tumor necrosis factor receptor (sTNF-R) used as a targeting agent to treat arthritis and other diseasesSMITH HENRY JOHN·Filed 2012·Application pending·0 cites
- 1047US2013115270A1Anti-interleukin-1 (IL-1) antibody used as a targeting agent to treat arthritis and other diseasesSMITH HENRY JOHN·Filed 2012·Application pending·0 cites
- 1147US2013115269A1Anti-tumor necrosis factor alpha (TNF-a) antibody used as a targeting agent to treat arthritis and other diseasesSMITH HENRY JOHN·Filed 2012·Application pending·0 cites
- 1246US2013068691A1Targeted apheresis for the treatment of rheumatoid arthritis and immune disordersSMITH HENRY JOHN·Filed 2012·Application pending·0 cites
- 1344US2018093032A1Targeted apheresis using binding agents or ligands immobilized on membranesSMITH HENRY JOHN·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SMITH HENRY JOHN files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →